Constipation Pipeline Insight, 2017 [Report Updated: 10072017] Prices from USD $2000

2017-08-12

DelveInsight's, Constipation Pipeline Insights, 2017, report provides comprehensive insights about pipeline drugs across this Constipation. The key objective of the report is to establish the understanding for all the pipeline drugs that are undergoing research across Constipation. This report provides information on the therapeutic development for Constipation, dealing with all the pipeline drugs and comparative analysis at various stages covering all clinical, preclinical as well as discovery products. The report further contains details on dormant products and discontinued products. Therapeutic assessment of all the active products by route of administration and molecule type is also covered in this report. The report is built using data and information sourced from proprietary databases, primary and secondary research and inhouse analysis by DelveInsight team of industry experts. Secondary sources information and data has been collected from various printable and nonprintable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases. Forest Labs and Ironwood Pharmaceuticals;AstraZeneca;Shionogi;Synergy Pharmaceuticals;Enterin Inc.;Kyowa Kirin Pharmaceutical Development Ltd;RaQualia Pharma Inc;AstraZeneca;KGK Synergize Inc.;Sucampo Pharmaceuticals Inc.;Ardelyx;Mundipharma China Pharmaceutical Co. Ltd;Purdue Pharma LP;Aboca Spa Societa' Agricola;Merck Sharp Dohme Corp.;Admescope Ltd;Yakult Constipation Pipeline Drugs Constipation Pipeline Assessment Constipation Pipeline Analysis Constipation Drugs under Development Constipation Discovery drugs Constipation Preclinical drugs Constipation Phase I drugs Constipation Phase II drugs Constipation Phase III Pipeline Drugs Assessment Constipation Preregistration drugs Constipation Molecules in pipeline

机构